Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01368835
Other study ID # ULT-106
Secondary ID
Status Completed
Phase N/A
First received June 6, 2011
Last updated November 16, 2017
Start date July 2010
Est. completion date April 2011

Study information

Verified date January 2014
Source Merz North America, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The clinical trial evaluates the clinical outcomes associated with the non-invasive treatment to obtain lift and tightening of the cheek tissue and improve jawline definition and submental skin laxity utilizing the Ulthera™ System which delivers ultrasound energy in a focused manner below the surface of the skin


Description:

The primary objective of this study is to demonstrate the effectiveness of the Ulthera™ System for the non-invasive dermatological treatment to obtain lift and tighten the cheek tissue.

The secondary objective of this study is to demonstrate the effectiveness of the Ulthera™ System for the non-invasive dermatological treatment for improvement in jawline definition and submental skin laxity at 3 and 6 months compared to baseline based on the consensus of the three masked reviewers.


Recruitment information / eligibility

Status Completed
Enrollment 103
Est. completion date April 2011
Est. primary completion date December 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 35 Years to 60 Years
Eligibility Inclusion Criteria:

- Male or female, aged 35 to 60 years

- Subject in good health

- Desire lift and tightening of cheek tissue, improvement of jawline definition or submental skin laxity

Exclusion Criteria:

- Pregnant or lactating

- Has an active systemic or local skin disease that may alter wound healing

- Severe solar elastosis

- Excessive subcutaneous fat on the cheeks

- Excessive skin laxity on the lower face and neck

- Has significant scarring in areas to be treated

- Has significant open facial wounds or lesions

- Has severe or cystic acne on the face

Study Design


Related Conditions & MeSH terms

  • Cutis Laxa
  • Mild to Moderate Skin Laxity on Cheek
  • Mild to Moderate Skin Laxity on Upper Neck
  • Mild to Moderate Subcutaneous Fat on Cheek
  • Mild to Moderate Subcutaneous Fat on Upper Neck

Intervention

Device:
Ulthera treatment
treatment of cheeks and upper neck area of face

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Ulthera, Inc University of Texas Southwestern Medical Center

Outcome

Type Measure Description Time frame Safety issue
Other Subject Assessment of Pain Subject assessment of pain using a validated Numeric Rating Scale (NRS), 0-10, where 0 = no pain and 10=worse pain possible. Subjects' sensory responses to the treatment exposures were recorded using the NRS for each anatomical region. During Ulthera study treatment
Primary Change in Overall Lifting and Tightening of Treated Tissue on the Lower Face and Submental Regions. The percentage of participants assessed to have improvement in skin laxity, i.e., lifted and tightened skin in the areas treated with the Ulthera System, as determined by three masked assessors comparing pre-treatment and 90-days post-treatment photos from 70 subjects who returned for their 90-day follow-up visit. 90D
Secondary Change in Submental and Neck Skin Laxity by Quantitative Analysis The percentage of participants assessed as having an improvement in tissue lift, i.e., >20mm2 in submental and neck skin laxity, at 90 Days post-treatment compared to baseline based on quantitative analysis. 90D
Secondary Patient Satisfaction Questionnaire Subjects indicated whether they saw improvement, i.e., providing a Yes/No response, in face and neck characteristics at three months (D90) post Ulthera treatment. Pre-treatment and Day 90 post-treatment photographs were available for viewing during the assessment. Subjects also had a mirror in hand for real time assessment. Subjects' Yes/No responses were tabulated. 90D